CoChat

AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain

Open access

Published version of a preprint

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index; 10 of the 45 sources its claims cite were checked for support.

Abstract

Adeno-associated viral (AAV) vector-based gene therapy is gaining foothold as treatment for genetic neurological diseases with encouraging clinical results. Nonetheless, dose-dependent adverse events have emerged in recent clinical trials through mechanisms that remain unclear. We have modelled here the impact of AAV transduction in cell models of the human central nervous system (CNS), taking advantage of induced pluripotent stem cells. Our work uncovers vector-induced innate immune mechanisms that contribute to cell death. While empty AAV capsids were well tolerated, the AAV genome triggered p53-dependent DNA damage responses across CNS cell types followed by the induction of inflammatory responses. In addition, transgene expression led to MAVS-dependent activation of type I interferon responses. Formation of DNA damage foci in neurons and gliosis were confirmed in murine striatum upon intraparenchymal AAV injection. Transduction-induced cell death and gliosis could be prevented by inhibiting p53 or by acting downstream on STING- or IL-1R-mediated responses. Together, our work identifies innate immune mechanisms of vector sensing in the CNS that can potentially contribute to AAV-associated neurotoxicity. Costa-Verdera et. al describe a mechanism by which AAV vector genomes activate P53-mediated signalling in CNS cells involving downstream STING activation and pro-inflammatory responses. Inhibition of either P53 or STING prevented target-cell apoptosis and inflammatory signalling.

Overview

CoChat Summary

TL;DR

In hiPSC-derived CNS models and mouse striatum, genome-containing AAV vectors—not empty capsids—trigger p53-dependent DNA damage responses followed by inflammatory and type I IFN signalling, with transgene expression enhancing inflammation. p53, STING, or IL-1R inhibition reduces pro-inflammatory signalling and/or cell death, while MAVS mediates type I IFN.

Key findings

  • Full AAV9, but not empty AAV9, induced DNA damage and death markers in hiPSC-derived neurons: increased p-γH2AX and cleaved caspase 3 (cC3) after 48 h; quantification used n = 9 coverslips untransduced, n = 5 empty, n = 11 full across 4 independent experiments. Empty AAV9 capsid caused no significant transcriptional changes versus untransduced controls, whereas full AAV9 did.
  • In mixed 2D cultures and 150-day 3D brain spheroids, scRNAseq showed early p53 activation followed by inflammatory and type I IFN signatures; GFP expression was higher in astrocytes and oligodendrocytes than neurons. A non-expressing hAAT-GFP vector triggered milder signalling limited mainly to oxidative phosphorylation, p53, and DNA repair, while CAG-driven transgene expression enhanced pro-inflammatory pathways.
  • In mice, bilateral intrastriatal AAV9-CAG-GFP (1 × 10^10 vg in 3 µl/hemisphere; 2 × 10^10 vg total) at 28 days induced p-γH2AX foci mainly in NeuN+ neurons, increased GFAP+Sox9+ astrocytes and Iba1+ microglia, and recruited CD45+ and CD3+ cells; snRNAseq used n = 2 mice/group, and IF used n = 3 AAV9 versus n = 2 vehicle.
  • Mechanistically, p53 inhibition with GSE56 completely abrogated CXCL8 and IL-1β induction, partially prevented ISGs, and rescued cC3 and LDH release; H151 (STING) or Anakinra (IL-1R) prevented pro-inflammatory responses without affecting p21/GDF15, and H151 rescued cell death in 2D neurons and mixed cultures. MAVS knockout diminished ISGs but not p21 or IL-1β. In vivo, p53, cGAS, or STING inhibition decreased GFAP+ cells but had no effect on Iba1+ cells and showed no NeuN+ neurotoxicity in that experiment.

Methods

  • Human iPSC-derived 2D neurons, astrocytes, mixed neuronal/glial cultures, and 3D brain spheroids (150 days) were transduced with AAV serotypes including AAV1, 2, 5, 6, 9, and Spk100, using full or empty capsids and CAG- or hAAT-driven transgenes; readouts included bulk RNAseq, scRNAseq, qPCR, flow cytometry, immunofluorescence, and CXCL8 ELISA.
  • Adult male C57BL/6J mice received bilateral intrastriatal AAV9-CAG-GFP or vehicle and were sacrificed 28 days post-injection for snRNAseq and immunofluorescence; a separate inhibitor study used pifithrin-α, RU.521, or H151 with striatal sections assessed 8 weeks post-injection.
  • Analyses included DESeq2, Hallmark GSEA, Seurat/Harmony or sctransform clustering, Cell Ranger, GSVA, and one-way ANOVA with Tukey or Bonferroni post-hoc tests.

Limitations

  • Stated: vector signalling was overall lower in mice than in vitro, possibly due to lower transduction or species-specific responses; animal models are less predictive of clinical outcomes; cGAS/STING and MAVS contributions need confirmation in genetic mouse models; clinical impact remains to be elucidated; microglia contribution warrants further study; duration of the insult is hard to predict in vitro.
  • Evident: the in vivo snRNAseq experiment used only n = 2 mice per group, and the IF comparison used n = 3 AAV9 versus n = 2 vehicle, limiting statistical power; the in vivo inhibitor experiment modulated GFAP+ cells but not Iba1+ cells, so gliosis effects were partial and cell-type restricted.
  • Evident: 2D versus 3D differences may be confounded by longer transduction time, longer differentiation/maturation, or MOI effects; transgene-negative populations may still contain undetected vector genomes or receive paracrine signals, complicating attribution of effects to transgene expression alone.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-58778-3

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Fig. 1 AAV vectors elicit transduction-dependent transcriptional alterations in hiPSC-derived neurons and astrocytes. Quantification of vector transduction efficiency by FACS analysis of GFP expression (A) and genome copy numbers (B) on hiPSC-derived neurons and astrocytes harvested 48 h post-transduction. Data are shown as mean between independent experiments (n = 3 for neurons, n = 3 for astrocytes transduced with AAV9, AAV5, Spk100 and UT; n = 2 for astrocytes transduced with AAV1, AAV2 and AAV6). C, D Heatmaps representing the level of differentially expressed genes (DEGs) in fold compared to untransduced (UT) samples. Each column constitutes one biological replicate. Heatmaps showing the enriched GSEA terms in hiPSC-derived neurons (E) and astrocytes (F) against the Hallmark gene set (Molecular Signatures Database). Each column represents the average between n = 3 biological replicates for all conditions except astrocytes UT (n = 4). GSEA was performed on logFC fold changes in gene expression in transduced samples compared to UT controls using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.01). Heatmaps showing the top upregulated and downregulated genes in hiPSC-derived neurons (G) and astrocytes (H) and the pathways they are associated with according to the Hallmark gene set. Source data are provided as a Source Data file.
Fig. 1 AAV vectors elicit transduction-dependent transcriptional alterations in hiPSC-derived neurons and astrocytes. Quantification of vector transduction efficiency by FACS analysis of GFP expression (A) and genome copy numbers (B) on hiPSC-derived neurons and astrocytes harvested 48 h post-transduction. Data are shown as mean between independent experiments (n = 3 for neurons, n = 3 for astrocytes transduced with AAV9, AAV5, Spk100 and UT; n = 2 for astrocytes transduced with AAV1, AAV2 and AAV6). C, D Heatmaps representing the level of differentially expressed genes (DEGs) in fold compared to untransduced (UT) samples. Each column constitutes one biological replicate. Heatmaps showing the enriched GSEA terms in hiPSC-derived neurons (E) and astrocytes (F) against the Hallmark gene set (Molecular Signatures Database). Each column represents the average between n = 3 biological replicates for all conditions except astrocytes UT (n = 4). GSEA was performed on logFC fold changes in gene expression in transduced samples compared to UT controls using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.01). Heatmaps showing the top upregulated and downregulated genes in hiPSC-derived neurons (G) and astrocytes (H) and the pathways they are associated with according to the Hallmark gene set. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 2 AAV9-mediated transduction activates functional DNA damage responses and apoptosis in hiPSC-derived neurons. A Immunofluorescence staining of phospho-γH2AX (p-γH2AX, red) and cleaved caspase 3 (cC3, green) in hiPSC-derived neurons transduced with empty or full AAV9 for 48 h. Scale bar 100 µm. Violin plots showing the quantification of p-γH2AX (B) and cC3 (C) intensities. N = 9 coverslips for untransduced (UT), n = 5 coverslips for Empty and n = 11 coverslips for Full-treated wells across cultures from 4 independent experiments. Data points refer to average values from 3–5 fields of view (FOV) per coverslip. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. Source data are provided as a Source Data file.
Fig. 2 AAV9-mediated transduction activates functional DNA damage responses and apoptosis in hiPSC-derived neurons. A Immunofluorescence staining of phospho-γH2AX (p-γH2AX, red) and cleaved caspase 3 (cC3, green) in hiPSC-derived neurons transduced with empty or full AAV9 for 48 h. Scale bar 100 µm. Violin plots showing the quantification of p-γH2AX (B) and cC3 (C) intensities. N = 9 coverslips for untransduced (UT), n = 5 coverslips for Empty and n = 11 coverslips for Full-treated wells across cultures from 4 independent experiments. Data points refer to average values from 3–5 fields of view (FOV) per coverslip. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 3 Single-cell transcriptomics of mixed neural cultures reveals time- and cell type- dependent activation of innate immunity pathways. A Scheme illustrating the differentiation process and transduction of hiPSC-derived mixed 2D cultures. Scheme created in BioRender. Costa, H. (2025) https://BioRender.com/u34k332. (B) UMAP plot of single-cell data generated with Seurat showing clustered untreated and treated samples from day 2. Cells are plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type in the UMAP shown in (B). D Quantification of the % of cells positive for GFP mRNA within each cell type for AAV9-treated samples on day 4. E Heat maps visualizing the enriched GSEA terms in total astrocytes, neurons and oligodendrocytes against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to untransduced (UT) within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).
Fig. 3 Single-cell transcriptomics of mixed neural cultures reveals time- and cell type- dependent activation of innate immunity pathways. A Scheme illustrating the differentiation process and transduction of hiPSC-derived mixed 2D cultures. Scheme created in BioRender. Costa, H. (2025) https://BioRender.com/u34k332. (B) UMAP plot of single-cell data generated with Seurat showing clustered untreated and treated samples from day 2. Cells are plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type in the UMAP shown in (B). D Quantification of the % of cells positive for GFP mRNA within each cell type for AAV9-treated samples on day 4. E Heat maps visualizing the enriched GSEA terms in total astrocytes, neurons and oligodendrocytes against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to untransduced (UT) within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).CC BY-NC-ND · PubMed Central
Fig. 4 AAV transduction leads to a time-dependent activation of DNA damage and inflammatory responses in 3D spheroids. A Scheme illustrating the differentiation process and transduction of hiPSC-derived 3D brain spheroids. Scheme partially created in BioRender. Costa, H. (2025) https://BioRender.com/u34k332. B UMAP plot of single-cell data generated with Seurat showing untreated and treated samples clustered. Cells are plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type in the UMAP shown in (B). D Quantification of the % of cells positive for GFP mRNA within each cell type on spheroids transduced with AAV9 after 5 days. E Heat maps visualizing the enriched GSEA terms in total astrocytes, neurons and oligodendrocytes against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to untransduced (UT) within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).
Fig. 4 AAV transduction leads to a time-dependent activation of DNA damage and inflammatory responses in 3D spheroids. A Scheme illustrating the differentiation process and transduction of hiPSC-derived 3D brain spheroids. Scheme partially created in BioRender. Costa, H. (2025) https://BioRender.com/u34k332. B UMAP plot of single-cell data generated with Seurat showing untreated and treated samples clustered. Cells are plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type in the UMAP shown in (B). D Quantification of the % of cells positive for GFP mRNA within each cell type on spheroids transduced with AAV9 after 5 days. E Heat maps visualizing the enriched GSEA terms in total astrocytes, neurons and oligodendrocytes against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to untransduced (UT) within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).CC BY-NC-ND · PubMed Central
Fig. 5 Inflammatory signatures are induced by different AAV serotypes and transgenes and depend on transgene expression. A Combinations of promoters and transgenes used to transduce 3D spheroids. Heat maps visualizing the enriched GSEA terms in (B) astrocytes, (C) oligodendrocytes, and (D) neurons either in the total population (left panel) or only in cells positive or negative for transgene mRNA (middle and right panels respectively) against the Hallmark gene set (Molecular Signatures Database) compared to untransduced controls within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction. The ubiquitous CAG promoter is highlighted in red (all panels) whereas the non-expressed hAAT promoter is coloured in grey (Transgene- panel only). (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).
Fig. 5 Inflammatory signatures are induced by different AAV serotypes and transgenes and depend on transgene expression. A Combinations of promoters and transgenes used to transduce 3D spheroids. Heat maps visualizing the enriched GSEA terms in (B) astrocytes, (C) oligodendrocytes, and (D) neurons either in the total population (left panel) or only in cells positive or negative for transgene mRNA (middle and right panels respectively) against the Hallmark gene set (Molecular Signatures Database) compared to untransduced controls within each cell type using Kolmogorov-Smirnov test with FDR for multiple test correction. The ubiquitous CAG promoter is highlighted in red (all panels) whereas the non-expressed hAAT promoter is coloured in grey (Transgene- panel only). (NES, normalized enrichment score; *, adjusted P < 0.05; **, adjusted P < 0.01; ***, adjusted P < 0.001).CC BY-NC-ND · PubMed Central
Fig. 6 AAV9-mediated CNS transduction induces pro-inflammatory signalling in vivo. A Study design. AAV9 vector or vehicle control were stereotactically injected bilaterally (B/L) into striatum of adult C57BL/6 J male mice. Striatum was collected 28 days post-injection for snRNAseq processing. Scheme partially created with BioRender. Dzhashiashvili, Y. (2025) https://BioRender.com/e92m679. B UMAP plot of mouse striatum single-nucleus data generated with Seurat. Cells from vehicle and AAV9-treated mice are clustered and plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type per treatment group. D Quantification of the percent of cells positive for GFP mRNA within each cell type. E Dot plots visualizing the enriched up-regulated GSEA terms in different cell types against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to vehicle within each cell type. Enriched pathways are ranked according to their normalized enrichment scores. Significance testing was performed with fgsea package in Bioconductor, comparing gene set enrichment scores to a null distribution of random permutations of the gene rankings. P-values were adjusted using the Benjamini-Hochberg correction to control FDR.
Fig. 6 AAV9-mediated CNS transduction induces pro-inflammatory signalling in vivo. A Study design. AAV9 vector or vehicle control were stereotactically injected bilaterally (B/L) into striatum of adult C57BL/6 J male mice. Striatum was collected 28 days post-injection for snRNAseq processing. Scheme partially created with BioRender. Dzhashiashvili, Y. (2025) https://BioRender.com/e92m679. B UMAP plot of mouse striatum single-nucleus data generated with Seurat. Cells from vehicle and AAV9-treated mice are clustered and plotted in two dimensions using the UMAP dimensionality reduction technique and annotated by cell type. C Donut plot showing the frequency of each cell type per treatment group. D Quantification of the percent of cells positive for GFP mRNA within each cell type. E Dot plots visualizing the enriched up-regulated GSEA terms in different cell types against the Hallmark gene set (Molecular Signatures Database). GSEA was performed on logFC pre-ranked gene lists obtained from gene expression levels of samples transduced with AAV9 compared to vehicle within each cell type. Enriched pathways are ranked according to their normalized enrichment scores. Significance testing was performed with fgsea package in Bioconductor, comparing gene set enrichment scores to a null distribution of random permutations of the gene rankings. P-values were adjusted using the Benjamini-Hochberg correction to control FDR.CC BY-NC-ND · PubMed Central
Fig. 7 AAV9-mediated CNS transduction induces functional DNA damage responses and gliosis in vivo. A Representative IF images of p-γH2AX staining (green) on striatum sections together with the neuron marker NeuN, the astrocyte marker Sox9 or the microglia marker iba1 in vehicle-treated mice (n = 2) compared to mice receiving intraparenchymal injection of an AAV9-CAG-GFP vector (n = 3) 4 weeks before sacrifice. Scale bar 100 µM. B Quantification of the total number of NeuN+, Sox9+, Iba1+ or total DAPI+ cells per section per animal from vehicle- (n = 2) and AAV9-treated (n = 3) animals. C Heatmap representation of the average percent values of NeuN+, Sox9+, Iba1+ or total DAPI+ cells that are positive for p-γH2AX in striatum sections from vehicle- (n = 2) vs. AAV9-treated (n = 3) animals. Source data are provided as a Source Data file.
Fig. 7 AAV9-mediated CNS transduction induces functional DNA damage responses and gliosis in vivo. A Representative IF images of p-γH2AX staining (green) on striatum sections together with the neuron marker NeuN, the astrocyte marker Sox9 or the microglia marker iba1 in vehicle-treated mice (n = 2) compared to mice receiving intraparenchymal injection of an AAV9-CAG-GFP vector (n = 3) 4 weeks before sacrifice. Scale bar 100 µM. B Quantification of the total number of NeuN+, Sox9+, Iba1+ or total DAPI+ cells per section per animal from vehicle- (n = 2) and AAV9-treated (n = 3) animals. C Heatmap representation of the average percent values of NeuN+, Sox9+, Iba1+ or total DAPI+ cells that are positive for p-γH2AX in striatum sections from vehicle- (n = 2) vs. AAV9-treated (n = 3) animals. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 8 AAV-induced pro-inflammatory signalling and apoptosis are dependent on p53. A Scheme of the experimental design for the transduction of hiPSC-derived astrocytes. Analysis of (B) P53-dependent genes, (C) ISGs and (D) cytokines and chemokines by qPCR in astrocytes at day 4 post-AAV2 transduction. Data are shown as mean ± SD between 3 independent experiments, each performed in technical duplicate. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. E Experimental design for the transduction of hiPSC-derived neurons. For A and E, schemes were partially created with Biorender. Costa, H. (2025) https://BioRender.com/u34k332. F Immunofluorescence staining of cC3 (red) in hiPSC-derived neurons at day 5 post-AAV9 transduction. Scale bar 100 µm. G Violin plot showing the quantification of cC3 staining. N = 31 FOVs for untransduced (UT), n = 36 FOVs for AAV9-CAG-GFP and n = 22 FOVs for AAV9-GFP + LV-GSE56 across cultures from 3 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. H LDH release assay performed on supernatants from neurons collected on day 5 post-AAV transduction. Data are shown as mean between 2 experimental replicates for all conditions except for AAV9 (n = 3). Source data are provided as a Source Data file.
Fig. 8 AAV-induced pro-inflammatory signalling and apoptosis are dependent on p53. A Scheme of the experimental design for the transduction of hiPSC-derived astrocytes. Analysis of (B) P53-dependent genes, (C) ISGs and (D) cytokines and chemokines by qPCR in astrocytes at day 4 post-AAV2 transduction. Data are shown as mean ± SD between 3 independent experiments, each performed in technical duplicate. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. E Experimental design for the transduction of hiPSC-derived neurons. For A and E, schemes were partially created with Biorender. Costa, H. (2025) https://BioRender.com/u34k332. F Immunofluorescence staining of cC3 (red) in hiPSC-derived neurons at day 5 post-AAV9 transduction. Scale bar 100 µm. G Violin plot showing the quantification of cC3 staining. N = 31 FOVs for untransduced (UT), n = 36 FOVs for AAV9-CAG-GFP and n = 22 FOVs for AAV9-GFP + LV-GSE56 across cultures from 3 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. H LDH release assay performed on supernatants from neurons collected on day 5 post-AAV transduction. Data are shown as mean between 2 experimental replicates for all conditions except for AAV9 (n = 3). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 9 AAV-induced signalling involves STING and IL-1R downstream of p53. A Experimental design for the treatment of hiPSC-derived astrocytes. Analysis of (B) p53-dependent genes, (C) cytokines and (D) ISGs by qPCR in hiPSC-derived astrocytes at day 4 post-AAV2 transduction. Data are shown as mean ± SD between 3 independent experiments. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. E Quantification of CXCL8 in culture supernatants from hiPSC-derived astrocytes measured by ELISA as mean ± SD between 3 independent experiments. Statistical significance was determined by one-way ANOVA with Bonferroni post-hoc test. F Experimental design for the treatment of hiPSC-derived neurons. For (A) and (F), schemes were partially created with Biorender. Costa, H. (2025) https://BioRender.com/u34k332. G Quantification of cC3 staining in hiPSC-derived neurons treated as in F harvested at day 5 post-AAV9 transduction. N = 40 FOVs for untransduced (UT) and AAV9, n = 36 FOVs for AAV9 + H151, across cultures from 3 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. (H) Immunofluorescence staining of the neuron marker Tuj1 and the astrocyte marker EAAT2 in mixed 2D cultures transduced with GFP. I Quantification of cC3 staining in hiPSC-derived mixed 2D cultures treated as in F harvested at day 5 post-AAV9 transduction. N = 24 FOVs for untransduced (UT) and AAV9 + H151, n = 25 FOVs for AAV9, across cultures from 2 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. For (G) and (I), statistical significance was determined by one-way ANOVA with Tukey post-hoc test. Source data are provided as a Source Data file.
Fig. 9 AAV-induced signalling involves STING and IL-1R downstream of p53. A Experimental design for the treatment of hiPSC-derived astrocytes. Analysis of (B) p53-dependent genes, (C) cytokines and (D) ISGs by qPCR in hiPSC-derived astrocytes at day 4 post-AAV2 transduction. Data are shown as mean ± SD between 3 independent experiments. Statistical significance was determined by one-way ANOVA with Tukey post-hoc test. E Quantification of CXCL8 in culture supernatants from hiPSC-derived astrocytes measured by ELISA as mean ± SD between 3 independent experiments. Statistical significance was determined by one-way ANOVA with Bonferroni post-hoc test. F Experimental design for the treatment of hiPSC-derived neurons. For (A) and (F), schemes were partially created with Biorender. Costa, H. (2025) https://BioRender.com/u34k332. G Quantification of cC3 staining in hiPSC-derived neurons treated as in F harvested at day 5 post-AAV9 transduction. N = 40 FOVs for untransduced (UT) and AAV9, n = 36 FOVs for AAV9 + H151, across cultures from 3 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. (H) Immunofluorescence staining of the neuron marker Tuj1 and the astrocyte marker EAAT2 in mixed 2D cultures transduced with GFP. I Quantification of cC3 staining in hiPSC-derived mixed 2D cultures treated as in F harvested at day 5 post-AAV9 transduction. N = 24 FOVs for untransduced (UT) and AAV9 + H151, n = 25 FOVs for AAV9, across cultures from 2 independent experiments, 3 coverslips per condition per experiment. Data points refer to individual fields of view. For (G) and (I), statistical significance was determined by one-way ANOVA with Tukey post-hoc test. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 23 Not checked · 99 Own results and interpretations

62 more claims

Create a free account to see all 129 claims and to verify the 35 references still open.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 44

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 103 references

Research works printed but not linked: 1

  1. Golebiowski, D. et al. Direct intracranial injection of AAVrh8 encoding monkey beta-N-Acetylhexosaminidase causes neurotoxicity in the primate brain. Hum. Gene Ther. 28, 510–522 (2017). · DOI · Paper page

Cited by

See all 32

Metadata

Authors
Costa-Verdera, H., Meneghini, V., Fitzpatrick, Z., Abou Alezz, M., Fabyanic, E., Huang, X., Dzhashiashvili, Y., Ahiya, A., Mangiameli, E., Valeri, E., Crivicich, G., Piccolo, S., Cuccovillo, I., Caccia, R., Chan, Y. K., Bertin, B., Ronzitti, G., Engel, E. A., Merelli, I., Mingozzi, F., Gritti, A., Kuranda, K., & Kajaste-Rudnitski, A.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • Spark Therapeutics (United States) (US)
  • The San Raffaele Telethon Institute for Gene Therapy (IT)
  • Harvard University (US)
  • Inserm (FR)
Venue
Nature Communications
Published
2025-04-18
Volume
16
Issue
1
Pages
3694-3694
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4409566313
Cited by
32
References
103
Citations by year
2026: 20 · 2025: 11
FWCI
18.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by-nc-nd)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Foundation for the National Institutes of Health (2022-BGTC003)
  • European Federation of Pharmaceutical Industries and Associations (945473)
  • European Commission (945473, HORIZON2020)
  • Fondazione Telethon
  • Spark Therapeutics
  • H2020 European Research Council (819815)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
adeno-associated virus vectors, AAV gene therapy, neurotoxicity, DNA damage response, p53, STING, innate immunity, type I interferon, MAVS, gliosis, iPSC-derived neurons, pro-inflammatory signaling, AAV capsid
MeSH terms
Dependovirus, Animals, Brain, Central Nervous System, DNA Damage, Genetic Vectors, Gliosis, Humans, Immunity, Innate, Inflammation, Mice, Inbred C57BL, Neurons, Transduction, Genetic, Genetic Therapy, Signal Transduction, Tumor Suppressor Protein p53, Mice, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain. https://app.cochat.ai/papers/10.1038/s41467-025-58778-3
The paper
Costa-Verdera, H., Meneghini, V., Fitzpatrick, Z., Abou Alezz, M., Fabyanic, E., Huang, X., Dzhashiashvili, Y., Ahiya, A., Mangiameli, E., Valeri, E., Crivicich, G., Piccolo, S., Cuccovillo, I., Caccia, R., Chan, Y. K., Bertin, B., Ronzitti, G., Engel, E. A., Merelli, I., . . . Kajaste-Rudnitski, A. (2025). AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain. Nature Communications. https://doi.org/10.1038/s41467-025-58778-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.